跳至主要内容
临床试验/NCT01007006
NCT01007006撤回不适用

Evaluation of a Telepharmacy Robotic Medicine Delivery Unit in Warrior Transition Unit Patients With Traumatic Brain Injury, Post-Traumatic Stress Disorder, or Polytrauma

University of Illinois at Chicago6 个研究点 分布在 1 个国家开始时间: 2010年12月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
试验地点
6
主要终点
Adherence

研究概览

简要总结

The objective of this study is to evaluate whether use of TRMDU in addition to medication review leads to improved outcomes and reduced health care costs for patients when compared with medication review alone. The study will be conducted in patients assigned to Department of Defense (DOD) Warrior Transition Units (WTU's), similar DOD units, and VA polytrauma centers.

详细描述

The military has been witnessing an increased number of patients with combat related impairments such as traumatic brain injury, post traumatic stress disorder and polytrauma which has lead to sub optimal medication self management. TRMDU is a medical device developed by INRange Systems Inc. that delivers medications and emits a sound alert to assist the patient. It can be used in a hospital, clinic, or residential setting. It can be remotely accessed by the health care professionals, and it allows physicians and other prescribers to remotely change scheduling or adjust prescriptions.

Use of TRMDU in hospital settings is expected to improve outcomes by improving medication self management, increasing adherence, reducing medication errors, and thereby associated costs. Further, it may contribute to overall improvement in a patient's psychological well-being and quality of life.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects must be
  • At least 18 years of age
  • Alert and oriented to person , place and time
  • Primarily use English language for written and oral communication
  • Have diagnosis of Traumatic Brain Injury(TBI) Multiple Traumatic Brain Injury (MTBI), Post Traumatic Stress Disorder (PTSD) or Polytrauma.
  • Taking at least 4 chronic prescription medications
  • Living in a participating WTU or enrolled in Tampa Veterans Administration polytrauma outpatient treatment facility at the time of enrollment
  • Achieve a minimum score of 24 on Mini-Mental State Examination

排除标准

  • If patients meet following criteria they are excluded from the study
  • Disabilities preventing safe use of the TRMDU
  • Projected life expectancy of less than 3 months

研究组 & 干预措施

TMRDU

Experimental

Telepharmacy Robotic Medicine Delivery Unit (TMRDU) group will receive TMRDU plus medication management

干预措施: TMRDU (Device)

Control

No Intervention

Control arm will receive only medication management, no TMRDU.

结局指标

主要结局

Adherence

时间窗: Six months

Pill counts and self report (Morisky 8-item)

次要结局

  • Intensity and type of pain(Three months)
  • Psychological well-being(Three months)
  • Health related quality of life(Three months)
  • Total cost of care(Six months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Daniel R. Touchette

Professor of Pharmacy

University of Illinois at Chicago

研究点 (6)

Loading locations...

相似试验

Telepharmacy Robotic Medicine Delivery Unit "TRMDU"... | 临床试验